Sleep Problems are Associated with Development and Progression of Lower Urinary Tract Symptoms: Results from REDUCE

被引:16
|
作者
Branche, Brandee L. [1 ]
Howard, Lauren E. [1 ,2 ]
Moreira, Daniel M. [3 ]
Roehrborn, Claus [4 ]
Castro-Santamaria, Ramiro [5 ]
Andriole, Gerald L. [6 ]
Hopp, Martin L.
Freedland, Stephen J. [1 ,7 ]
机构
[1] Duke Univ, Sch Med, Durham Vet Affairs Med Ctr, Surg Sect, Durham, NC USA
[2] Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC USA
[3] Univ Illinois, Chicago, IL USA
[4] Univ Texas Southwestern, Med Ctr, Dallas, TX USA
[5] GlaxoSmithKline Inc, Metab Pathways & Cardiovasc R&D Unit, King Of Prussia, PA USA
[6] Washington Univ, Sch Med, St Louis, MO USA
[7] Cedars Sinai Med Ctr, 8635 West 3rd St,Suite 1070W, Los Angeles, CA 90048 USA
来源
JOURNAL OF UROLOGY | 2018年 / 199卷 / 02期
基金
美国国家卫生研究院;
关键词
prostate; prostatic hyperplasia; lower urinary tract symptoms; sleep; patient reported outcome measures; PROSTATE-CANCER EVENTS; OBESITY; TRIAL; DUTASTERIDE; METABOLISM; NOCTURIA; SCALE; TIME; RISK; MEN;
D O I
10.1016/j.juro.2017.08.108
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Although lower urinary tract symptoms and sleep problems often develop together, to our knowledge it is unknown whether sleep disturbances are linked to lower urinary tract symptoms development and progression. As measured by the 6-item MOS-Sleep (Medical Outcomes Study Sleep Scale) survey we examined the relationship between sleep problems, and the development and progression of lower urinary tract symptoms in the REDUCE (Reduction by Dutasteride of Prostate Cancer Events) study. Materials and Methods: REDUCE was a randomized trial testing prostate cancer chemoprevention with dutasteride in men with prostate specific antigen 2.5 to 10 ng/ml and a negative biopsy. At baseline men completed MOS-Sleep and a scaled average was used to calculate the sleep score. Men were followed for 4 years and I-PSS (International Prostate Symptom Score) was completed at baseline and every 6 months. Asymptomatic men had I-PSS less than 8 while symptomatic men had I-PSS 8 or greater. In the placebo arm of 2,588 men not receiving a-blockers or 5a-reductase inhibitors at baseline we tested the association between sleep problems and lower urinary tract symptom development and progression using Cox models. Results: During followup lower urinary tract symptoms developed in 209 of 1,452 asymptomatic men (14%) and 580 of 1,136 (51%) with lower urinary tract symptoms demonstrated progression. On multivariable analysis higher sleep scores were suggestively associated with increased lower urinary tract symptoms in asymptomatic men (quartile 4 vs 1 HR 1.41, 95% CI 0.92-2.17, p = 0.12) and with lower urinary tract symptom progression in symptomatic men (per 10 points of sleep score HR 1.06, 95% CI 1.01-1.12, p = 0.029). Conclusions: Among men with lower urinary tract symptoms worse sleep scores were associated with the progression of lower urinary tract symptoms and among asymptomatic men worse sleep scores were suggestively associated with the development of lower urinary tract symptoms. If confirmed, these data suggest that sleep problems may precede such symptoms. Whether treating sleep problems would improve lower urinary tract symptoms requires further testing.
引用
收藏
页码:536 / 542
页数:7
相关论文
共 50 条
  • [1] Sleep Problems are Associated with Development and Progression of Lower Urinary Tract Symptoms: Results from REDUCE EDITORIAL COMMENT
    Helfand, Brian
    JOURNAL OF UROLOGY, 2018, 199 (02): : 542 - 542
  • [2] SERUM CHOLESTEROL AND RISK OF LOWER URINARY TRACT SYMPTOMS PROGRESSION: RESULTS FROM THE REDUCE STUDY
    Feng, Tom
    Howard, Lauren
    Vidal, Adriana
    Moreira, Daniel
    Castro-Santamaria, Ramiro
    Andriole, Gerald
    Freedland, Stephen
    JOURNAL OF UROLOGY, 2016, 195 (04): : E485 - E485
  • [3] Serum Testosterone and Dihydrotestosterone and Incidence and Progression of Lower Urinary Tract Symptoms: Results From the REDUCE Study
    Daniels, James P.
    Mirocha, James
    Adjei, Michie
    Moreira, Daniel
    Freedland, Stephen J.
    JOURNAL OF UROLOGY, 2024, 211 (01): : 101 - 110
  • [4] PSA PREDICTS DEVELOPMENT OF INCIDENT LOWER URINARY TRACT SYMPTOMS: RESULTS FROM THE REDUCE STUDY
    Feng, Tom
    Simon, Ross
    Howard, Lauren
    Vidal, Adriana
    Moreira, Daniel
    Castro-Santamaria, Ramiro
    Andriole, Gerald
    Roehrborn, Claus
    Freedland, Stephen
    JOURNAL OF UROLOGY, 2016, 195 (04): : E484 - E484
  • [5] PSA predicts development of incident lower urinary tract symptoms: results from the REDUCE study
    Patel, Devin N.
    Feng, Tom
    Simon, Ross M.
    Howard, Lauren E.
    Vidal, Adriana C.
    Moreira, Daniel M.
    Castro-Santamaria, Ramiro
    Roehrborn, Claus
    Andriole, Gerald L.
    Freedland, Stephen J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2018, 21 (02) : 238 - 244
  • [6] PSA predicts development of incident lower urinary tract symptoms: results from the REDUCE study
    Devin N. Patel
    Tom Feng
    Ross M. Simon
    Lauren E. Howard
    Adriana C. Vidal
    Daniel M. Moreira
    Ramiro Castro-Santamaria
    Claus Roehrborn
    Gerald L. Andriole
    Stephen J. Freedland
    Prostate Cancer and Prostatic Diseases, 2018, 21 : 238 - 244
  • [7] THE EFFECT OF STATINS ON DEVELOPMENT OF SIGNIFICANT LOWER URINARY TRACT SYMPTOMS: RESULTS FROM THE REDUCE STUDY
    Feng, Tom
    Howard, Lauren
    Vidal, Adriana
    Moreira, Daniel
    Castro-Santamaria, Ramiro
    Andriole, Gerald
    Freedland, Stephen
    JOURNAL OF UROLOGY, 2016, 195 (04): : E462 - E462
  • [8] Letter: Serum Testosterone and Dihydrotestosterone and Incidence and Progression of Lower Urinary Tract Symptoms: Results From the REDUCE Study
    Chang, Kuo-Chen
    Hung, Shun-Fa
    JOURNAL OF UROLOGY, 2024, 211 (05): : 714 - 714
  • [9] The Relationship between Sleep Disorders and Lower Urinary Tract Symptoms: Results from the NHANES
    Fantus, Richard J.
    Packiam, Vignesh T.
    Wang, Chi H.
    Erickson, Bradley A.
    Helfand, Brian T.
    JOURNAL OF UROLOGY, 2018, 200 (01): : 161 - 166
  • [10] Sleep disturbances and lower urinary tract symptoms
    McVary K.T.
    Current Urology Reports, 2011, 12 (4) : 243 - 244